Tag: Biotest Pharmaceuticals

July 8, 2019

ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®

ADMA Biologics NASDAQ:ADMA) has announced that the US Food and Drug Administration (FDA) has revoked the licenses for BIVIGAM and...